Provided by Tiger Trade Technology Pte. Ltd.

Johnson & Johnson

265.58
-0.7700-0.29%
Post-market: 266.200.6200+0.23%19:59 EDT
Volume:4.71M
Turnover:1.26B
Market Cap:639.86B
PE:30.75
High:270.40
Open:268.03
Low:265.25
Close:266.35
52wk High:281.07
52wk Low:173.33
Shares:2.41B
Float Shares:2.40B
Volume Ratio:0.80
T/O Rate:0.20%
Dividend:5.24
Dividend Rate:1.97%
EPS(TTM):8.64
EPS(LYR):11.03
ROE:25.74%
ROA:8.59%
PB:7.53
PE(LYR):24.07

Loading ...

Johnson & Johnson (JNJ) Stock May Trade At A Discount As Europe Backs Tecvayli

Simply Wall St.
·
Sep 01

Global Pharma Companies That Have Publicly Announced Trump Drug Pricing Agreements

Reuters
·
Sep 01

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Sep 01

Johnson & Johnson Schedules Investor Call to Discuss Third-Quarter Results

Reuters
·
Sep 01

Protagonist Therapeutics' Own Pipeline Seen as Main Long-Term Growth Driver, Wedbush Says

MT Newswires Live
·
Aug 31

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 29

US FDA - Approves Stelara for Pediatric Ulcerative Colitis

THOMSON REUTERS
·
Aug 29

Lobe Sciences Names David Kideckel CFO as Mirza Rahimani Shifts to VP Finance

Reuters
·
Aug 28

Medtronic PLC Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Aug 28

China Approves J&J's Oral Psoriasis Pill, Says Drugmaker

Reuters
·
Aug 27

Johnson & Johnson Says Oral Icotrokinra Approved in China for Moderate-to-Severe Plaque Psoriasis - Statement

THOMSON REUTERS
·
Aug 27

US FDA - Issues Early Alert on Abiomed Heart Pump Controller Purge Cassette Issue

THOMSON REUTERS
·
Aug 27

Analysts Are Bullish on These Healthcare Stocks: Zymeworks (ZYME), Johnson & Johnson (JNJ)

TIPRANKS
·
Aug 26

Johnson & Johnson (JNJ) Wins FDA Approval For First Warm Autoimmune Hemolytic Anemia Treatment

Simply Wall St.
·
Aug 26

Perrigo Co. PLC Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 26

Moderna Inc Stock (MRNA) Moved Up by 10.02% on Aug 25: Drivers Behind the Movement

TradingKey
·
Aug 25

Parabilis Medicines Appoints Former J&J Oncology Executive Craig Tendler to Board

Reuters
·
Aug 25

US FDA Expands Approval for J&J's Drug for Rare Blood Disorder

Reuters
·
Aug 25

FDA Approves J&J Imaavy for Warm Autoimmune Hemolytic Anemia Treatment

Reuters
·
Aug 25

FDA Approves Imaavy® as First-Ever Treatment for Warm Autoimmune Hemolytic Anemia (Waiha), Representing a Landmark Advancement for Patients

THOMSON REUTERS
·
Aug 25